Biolipox Overview
- Year Founded
-
2000
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$135M
Biolipox General Information
Description
Provider of drugs for inflammatory diseases. The company is focused on therapies for inflammatory diseases including pain management and respiratory diseases like asthma and chronic obstructive pulmonary disease.
Contact Information
Website
biolipox.comCorporate Office
- Berzelius väg 3
- plan 5
- 171 65 Solna
- Sweden
Corporate Office
- Berzelius väg 3
- plan 5
- 171 65 Solna
- Sweden
Biolipox Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 23-Nov-2007 | $135M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series C) | 10-Oct-2005 | Completed | Startup | |||
| 3. Grant | 26-Feb-2005 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 22-Jan-2003 | $22.1M | $26.5M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 01-Mar-2001 | $4.43M | $4.43M | Completed | Startup |
Biolipox Patents
Biolipox Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201507752-D0 | New compounds and uses | Inactive | 06-May-2015 | ||
| GB-201507753-D0 | New compounds and uses | Inactive | 06-May-2015 | ||
| GB-201407596-D0 | New compounds and uses | Inactive | 30-Apr-2014 | ||
| GB-201407599-D0 | New compounds and uses | Inactive | 30-Apr-2014 | ||
| GB-201307201-D0 | New compounds and uses | Inactive | 22-Apr-2013 |
Biolipox Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biolipox Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Apax Partners | PE/Buyout | Minority | ||
| Auriga Partners (Paris) | Venture Capital | Minority | ||
| Credit Lyonnais Private Equity | PE/Buyout | Minority | ||
| HealthCap | Venture Capital | Minority | ||
| Scandinavian Life Science Venture | Venture Capital | Minority |
Biolipox Investments (1)
Biolipox’s most recent deal was a Corporate Asset Purchase with Inflazyme Pharmaceuticals (Research & Development assets) for . The deal was made on 19-Nov-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Inflazyme Pharmaceuticals (Research & Development assets) | 19-Nov-2007 | Corporate Asset Purchase | Buildings and Property |
Biolipox FAQs
-
When was Biolipox founded?
Biolipox was founded in 2000.
-
Where is Biolipox headquartered?
Biolipox is headquartered in Solna, Sweden.
-
What is the size of Biolipox?
Biolipox has 9 total employees.
-
What industry is Biolipox in?
Biolipox’s primary industry is Drug Discovery.
-
Is Biolipox a private or public company?
Biolipox is a Private company.
-
What is the current valuation of Biolipox?
The current valuation of Biolipox is .
-
What is Biolipox’s current revenue?
The current revenue for Biolipox is .
-
How much funding has Biolipox raised over time?
Biolipox has raised $67.5M.
-
Who are Biolipox’s investors?
Apax Partners, Auriga Partners (Paris), Credit Lyonnais Private Equity, HealthCap, and Scandinavian Life Science Venture are 5 of 6 investors who have invested in Biolipox.
-
When was Biolipox acquired?
Biolipox was acquired on 23-Nov-2007.
-
Who acquired Biolipox?
Biolipox was acquired by Orexo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
